Skip to content
Innovative Tech
Diseases
Health Policy
HTA
Data Analysis
Clinical Practice
Contributors
BACK TO MAIN SITE
The Role of Pull Incentives in Addressing Antim...
By
HEOR Staff Writer
June 26, 2024
Introduction Antimicrobial resistance (AMR) is a growing global health threat. According to rece...
Cost-Utility and Cost-Effectiveness of Disease-Modifying Drugs for Relapsing-...
The Impact of Time Horizons on QALY Calculations in Healthcare
Healthcare Decision-Making with MCDA Framework: The Saudi Arabian Perspective
Use of AI in Genetic Diagnosis: Identifying Rare Diseases
Managing Access to Medicines in the Future: Innovations and Strategies
The Influence of AI on Risk Adjustment Models in Healthcare
A Cost-Effectiveness Analysis of Emicizumab Treatment in Non-Severe Haemophil...
Clinical Trials in Saudi Arabia: An Insight from PDC-CRO
A Global Perspective on Orphan Medicines and Rare Diseases
CHMP’s February 2024 Meeting: New Drug Recommendations
Sotatercept for Pulmonary Arterial Hypertension Patients
Groundbreaking Medical Innovations in 2023: FDA approvals
« Previous
1
2
3
4
5
Next »